Cerebroprotective Potential of Andrographolide Nanoparticles: In silico and In vivo Investigations

Abstract

Ischemic stroke remains the leading cause of death and disability, while the main mechanisms of dominant neurological damage in stroke contain oxidative stress and inflammation. Docking studies revealed a binding energy of − 6.1 kcal/mol for AG, while the co-crystallized ligand (CCl) exhibited a binding energy of − 7.3 kcal/mol with NOS. AG demonstrated favourable hydrogen bond interactions with amino acids ASN A:354 and ARG A:388 and hydrophobic interactions with GLU A:377. Molecular dynamics simulations throughout 100 ns indicated a binding affinity of − 27.65±2.88 kcal/mol for AG, compared to − 18.01±4.02 kcal/mol for CCl. These findings suggest that AG possesses a superior binding affinity for NOS compared to CCl, thus complementing the stability of NOS at the docked site.AG has limited applications owing to its low bioavailability, poor water solubility, and high chemical and metabolic instability.The fabrication method was employed in the preparation of AGNP, SEM analysis confirmed spherical shape with size in 19.4±5 nm and investigated the neuroprotective effect in cerebral stroke rats induced by 30 min of carotid artery occlusion followed by 4 hr reperfusion, evaluated by infarction size, ROS/RNS via GSH, MPO, NO estimationand AchE activity, and monitoring EEG function. Cortex and hippocampal histology were compared between groups. AGNP treatment significantly decreased Infarction size and increased GSH levels (p<0.01^**), decreased MPO (p<0.01^**), NO (p<0.01^**), AchE (p<0.01^**), restored to normal EEG amplitude, minimizing unsynchronized polyspikes and histological data revealed that increased pyramidal cell layer thickness and decreased apoptotic neurons in hippocampus, cortex appeared normal neurons with central large vesicular nuclei, containing one or more nucleoli in compared to AG treatment. Based on brain biochemical, histopathology reports AGNP exhibited significant cerebroprotective activity compared to AG on ischemic rats.

Keywords

andrographolide - cerebral stroke - in silico - reactive oxygen species - reactive nitrogen species - nitric oxide synthase

Publikationsverlauf

Eingereicht: 02. Januar 2024

Angenommen: 02. April 2024

Artikel online veröffentlicht:
11. Juli 2024

• References

• 1 Nian K, Harding IC, Herman IM. et al. Blood-brain barrier damage in ischemic stroke and its regulation by endothelial mechanotransduction. Front Physiol 2020; 11: 605398
• 2 Ma Q, Li R, Wang L. et al. Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2021; 6: e897-e906
• 3 Khoshnam SE, Winlow W, Farbood Y. et al. Emerging roles of microRNAs in ischemic stroke: as possible therapeutic agents. J Stroke 2017; 19: 166
• 4 Duncan AJ, Heales SJ. Nitric oxide and neurological disorders. Mol Aspects Med 2005; 26: 67-96
• 5 Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005; 2: 3-14
• 6 Pillay V, Choonara YE. Advances in Neurotherapeutic Delivery Technologies. OMICS International; Los Angeles, CA, USA: 2015
• 7 Masserini M. Nanoparticles for brain drug delivery. Int Sch Res Notices. 2013 2013. 238428
• 8 Jayakumar T, Hsieh CY, Lee JJ. et al. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med. 2013 2013. 846740
• 9 Dai GF, Zhao J, Jiang ZW. et al. Anti-inflammatory effect of novel andrographolide derivatives through inhibition of NO and PGE2 production. Int Immunopharmacol 2011; 11: 2144-2149
• 10 Thakur AK, Rai G, Chatterjee S. et al. Analgesic and anti-inflammatory activity of Andrographis paniculata and andrographolide in diabetic rodents. EC Pharm Sci 2015; 1: 19-28
• 11 Suebsasana S, Pongnaratorn P, Sattayasai J. et al. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 2009; 32: 1191-1200
• 12 Saranya P, Geetha A, Selvamathy SN. A biochemical study on the gastroprotective effect of andrographolide in rats induced with gastric ulcer. Indian J Pharm Sci 2011; 73: 550
• 13 Lu J, Ma Y, Wu J. et al. A review for the neuroprotective effects of andrographolide in the central nervous system. Biomed Pharmacother 2019; 117: 109078
• 14 Tapia-Rojas C, Schüller A, Lindsay CB. et al. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo. Biochem J 2015; 466: 415-430
• 15 Chan SJ, Wong WF, Wong PT. et al. Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. British J Pharmacol 2010; 161: 668-679
• 16 Vamshi G, DSNBK P, Sampath A. et al. Possible cerebroprotective effect of citronellal: molecular docking, MD simulation and in vivo investigations. J Biomol Struct Dyn 2024; 42: 1208-1219
• 17 Praveen Kumar P, Sunil Kumar KT, Kavya Nainita M. et al. Cerebroprotective potential of hesperidin nanoparticles against bilateral common carotid artery occlusion reperfusion injury in rats and in silico approaches. Neurotox Res 2020; 37: 264-274
• 18 Othman IM, Mahross MH, Gad-Elkareem MA. et al. Toward a treatment of antibacterial and antifungal infections: Design, synthesis and in vitro activity of novel arylhydrazothiazolylsulfonamides analogues and their insight of DFT, docking and molecular dynamic simulations. J Mol Struct 2021; 1243: 130862
• 19 Burley SK, Bhikadiya C, Bi C. et al. RCSB Protein Data bank: Tools for visualizing and understanding biological macromolecules in 3D. Protein Sci 2022; 31: e4482
• 20 Etsassala NG, Badmus JA, Marnewick JL. et al. Alpha-glucosidase and alpha-amylase inhibitory activities, molecular docking, and antioxidant capacities of Salvia aurita constituents. Antioxidants 2020; 9: 1149
• 21 Prasanth DS, Singh G, Panda SP. et al. In silico screening of plant-derived anti-virals from Shorea hemsleyana (King) king ex Foxw against SARS CoV-2 main protease. Chemistry Africa 2023; 6: 345-366
• 22 Rudrapal M, Eltayeb WA, Rakshit G. et al. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies. Sci Rep 2023; 13: 8656
• 23 Issahaku AR, Salifu EY, Agoni C. et al. Discovery of potential KRAS-SOS1 inhibitors from South African natural compounds: An in silico approach. ChemistrySelect 2023; 8: e202300277
• 24 Baru Venkata R, Prasanth DS, Pasala PK. et al. Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: Investigation of antikindling and antioxidant activities through in silico and in vivo studies. Front Nutr 2023; 10: 1185236
• 25 Bederson JB, Pitts LH, Tsuji M. et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986; 17: 472-476
• 26 Gl E. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77
• 27 Grisham MB, Johnson GG, Lancaster JR. Quantitation of nitrate and nitrite in extracellular fluids. In: Methods in Enzymology. 1996. 268. pp. 237-246 Academic Press;
• 28 Ellman GL, Courtney KD, Andres V. et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95
• 29 Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001; 5: 62-71
• 30 Saha S, Panagiotou S. Therapeutic benefits of nanoparticles in stroke. Front Cell Neurosci 2015; 9: 182
• 31 Sarmah D, Saraf J, Kaur H. et al. Stroke management: An emerging role of nanotechnology. Micromachines 2017; 8: 262
• 32 Kyle S, Saha S. Nanotechnology for the detection and therapy of stroke. Adv Healthc Mater 2014; 3: 1703-1720
• 33 Lu CX, Qiu T, Liu ZF. et al. Calcitonin gene-related peptide has protective effect on brain injury induced by heat stroke in rats. Exep Ther Med 2017; 14: 4935-4941
• 34 Sifat AE, Vaidya B, Abbruscato TJ. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke. AAPS J 2017; 19: 957-972
• 35 Nita DA, Nita V, Spulber S. et al. Oxidative damage following cerebral ischemia depends on reperfusion-a biochemical study in rat. J Cell Mol Med 2001; 5: 163-170
• 36 Chen S, Chen H, Du Q. et al. Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: Potential application of natural compounds. Front Physiol 2020; 11: 433
• 37 Kader A, Frazzini VI, Solomon RA. et al. Nitric oxide production during focal cerebral ischemia in rats. Stroke 1993; 24: 1709-1716
• 38 Moro MA, Almeida A, Bolaños JP. et al. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic Biol Med 2005; 39: 1291-1304
• 39 Muley MM, Thakare VN, Patil RR. et al. Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: a comparative evaluation with piracetam and protocatachuic acid. Pharmacol Biochem Behav 2012; 102: 286-293
• 40 Hu T, Fu Q, Liu X. et al. Increased acetylcholinesterase and capase-3 expression in the brain and peripheral immune system of focal cerebral ischemic rats. J Neuroimmunol 2009; 211: 84-91